HUMA profile · all as-reported value updates
Humacyte, Inc. (HUMA) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Stockholders' equity | 2020 | 5,000,006 | -350,317,000 | -355,317,006 | -101.43% | revised comparative figure | 0001213900-21-009571 0001818382-23-000016 | 4 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2020 | 1,094,761 | 39,929,000 | 38,834,239 | +97.26% | revised comparative figure | 0001213900-21-009571 0001818382-22-000011 | 3 filed observations examined for this concept and period. |
| Liabilities | 2020 | 2,095,733 | 36,016,000 | 33,920,267 | +94.18% | revised comparative figure | 0001213900-21-009571 0001818382-22-000011 | 3 filed observations examined for this concept and period. |
| Assets | 2020 | 101,259,899 | 106,688,000 | 5,428,101 | +5.09% | revised comparative figure | 0001213900-21-009571 0001818382-22-000011 | 3 filed observations examined for this concept and period. |